Literature DB >> 18073166

Microbiology of community-acquired pneumonia in the Gulf Corporation Council states.

Z A Memish1, Q A Ahmed, Y M Arabi, A M Shibl, M S Niederman.   

Abstract

In spite of advances in microbiological and serological investigations over the last two decades, etiological attribution remains difficult in community-acquired pneumonia (CAP). Even after exhaustive investigation, the etiology of CAP remains unknown in up to 50% of patients. Common pathogens include Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. In addition, several investigators document the importance of atypical pathogens including Mycoplasma pneumoniae, Chlamydophila pneumoniae and Legionella pneumophila in the etiology of CAP in the GCC region. Increasingly, other etiologies, particularly influenza viruses, varicella zoster virus and Mycobacterium tuberculosis, have been recognized as causative pathogens of CAP within the region. Rates of antimicrobial resistance of S. pneumoniae and other pathogens are rising in the Gulf Corporation Council (GCC) region and susceptibility profiles of antibiotics against intracellular pathogens such as Chlamydophila pneumoniae and Mycoplasma pneumoniae are not routinely performed. Injudicious prescribing and over-use of antibiotics drive much resistance. The GCC CAPWG calls for urgent governmental regulations to limit and monitor antibiotic prescription in the GCC region.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18073166     DOI: 10.1080/1120009x.2007.11782430

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  12 in total

1.  Susceptibilities of common bacterial isolates from oman to old and new antibiotics.

Authors:  Mubarak Al-Yaqoubi; Kamal Elhag
Journal:  Oman Med J       Date:  2008-07

2.  Evaluation of antibiotic prescribing for adult inpatients at Sultan Qaboos University Hospital, Sultanate of Oman.

Authors:  Ghada Redha Al-Maliky; Mustafa Manhal Al-Ward; Aqila Taqi; Abdullah Balkhair; Ibrahim Al-Zakwani
Journal:  Eur J Hosp Pharm       Date:  2017-05-09

Review 3.  β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.

Authors:  Hosam M Zowawi; Hanan H Balkhy; Timothy R Walsh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Knowledge, attitude and practice towards antibiotic use among the public in Kuwait.

Authors:  Abdelmoneim Ismail Awad; Esraa Abdulwahid Aboud
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

Review 5.  Race Against Antimicrobial Resistance Requires Coordinated Action - An Overview.

Authors:  J Premanandh; B S Samara; A N Mazen
Journal:  Front Microbiol       Date:  2016-02-02       Impact factor: 5.640

Review 6.  WHO Global Priority Pathogens List: A Bibliometric Analysis of Medline-PubMed for Knowledge Mobilization to Infection Prevention and Control Practices in Bahrain.

Authors:  Govindaraj V Asokan; Tufoof Ramadhan; Eman Ahmed; Hala Sanad
Journal:  Oman Med J       Date:  2019-05

7.  Public practices on antibiotic use: A cross-sectional study among Qatar University students and their family members.

Authors:  Ghadir Fakhri Aljayyousi; Manar E Abdel-Rahman; Asmaa El-Heneidy; Rana Kurdi; Eman Faisal
Journal:  PLoS One       Date:  2019-11-26       Impact factor: 3.240

8.  The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries.

Authors:  Mahmoud Aly; Hanan H Balkhy
Journal:  Antimicrob Resist Infect Control       Date:  2012-07-19       Impact factor: 4.887

Review 9.  Knowledge, attitude, perception and practice regarding antimicrobial use in upper respiratory tract infections in Qatar: a systematic review.

Authors:  F Shaikhan; S Rawaf; A Majeed; S Hassounah
Journal:  JRSM Open       Date:  2018-09-03

10.  Etiology of severe community-acquired pneumonia during the 2013 Hajj-part of the MERS-CoV surveillance program.

Authors:  Ziad A Memish; Malak Almasri; Abdulhafeez Turkestani; Ali M Al-Shangiti; Saber Yezli
Journal:  Int J Infect Dis       Date:  2014-06-23       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.